News by Tag: Myocardial Infarction
Emerging World Pharma Inc. Strategic Partner African Global Pharma GH Adds Beta-Blocker, Glaten® To Over-The-Counter Lineup
November 12, 2012
African Global Pharma Corp.(AGP) has added the beta-adrenoceptors blocker Glaten® to its over-the-counter line of pharmaceuticals. The medication contains Atenolol and is used for the treatment of hypertension, angina and myocardial infarction.
November 12, 2012
African Global Pharma Corp.(AGP) has added the beta-adrenoceptors blocker Glaten® to its over-the-counter line of pharmaceuticals. The medication contains Atenolol and is used for the treatment of hypertension, angina and myocardial infarction.